Image Place holder

Amber Orman, MD

Specialty: Radiation Oncology
Program: Radiation Oncology

Call 1-888-MOFFITT

or call 1-888-MOFFITT


Dr. Amber Orman is an Assistant Member in the Department of Radiation Oncology, with a secondary appointment in the Department of Oncologic Sciences at the University of South Florida. Dr. Orman’s clinical focus is breast cancer, with an emphasis on holistic care that encompasses both mind and body. Dr. Orman’s primary research interest is in integrative therapies and their applications to cancer prevention, treatment and survivorship. She is especially focused on nutrition and the microbiome. Dr. Orman graduated summa cum laude from Rose-Hulman Institute of Technology with a degree in Applied Biology. Upon graduation, she received the John T. Royse Award, which is presented to the senior who on the basis of academic achievement, student leadership, and citizenship is considered by the faculty and staff to be the most outstanding graduate. Dr. Orman then received her MD degree from the Indiana University School of Medicine in Indianapolis. There, she was awarded with the John H. Edwards Fellowship, one of Indiana University’s most prestigious academic awards based on good citizenship, character, scholastic ability and intellectual capacity. She then completed her Radiation Oncology residency at the University of Miami Miller School of Medicine, where she served as Chief Resident. Dr. Orman has published on a wide variety of topics including prostate cancer, pediatric retinoblastoma, occult primary breast cancer, and head and neck cancer, and she has presented research at multiple national meetings. For her accomplishments, she was awarded the Radiological Society of North America Roentgen Resident/Fellow Research Award. She joined the Moffitt Cancer Center Department of Radiation Oncology Breast Section in 2015. Dr. Orman believes in treating not only the cancer at hand, but also the whole patient. She believes in interventions that improve outcomes as well as quality of life, both during and after treatment. Dr. Orman also focuses on health promotion strategies during cancer survivorship, with the goals of decreasing the risk of a subsequent battle with cancer, minimizing co-morbidities, and improving overall health long term.  

Education & Training

Board Certification:

  • Radiation Oncology


  • St. Vincent Hospital - Transitional Medicine
  • University of Miami Miller School of Medicine - Radiation Oncology

Medical School:

  • Indiana University School of Medicine - MD
Participating Trials

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients who have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Condition: Breast

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Condition: Breast
Intervention: Not Applicable

A Phase I Dose Escalation Study of Preoperative Stereotactic Body Radiation Therapy (SBRT) for High Risk Prostate Cancer
Condition: Genitourinary
Intervention: Not Applicable

A Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy
Condition: Breast
Intervention: Not Applicable

If you believe you are eligible for one of these trials or studies, please call
1-888-MOFFITT (1-888-663-3488).


  • Mellon EA, Orman A, Joya LE, Montejo ME, Laronga C, Hoover SJ, Lee MC, Khakpour N, Kubal PF, Diaz R. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy. Brachytherapy. 2017 Jul;16(1):174-180. Pubmedid: 27816540.
  • Parra NA, Orman A, Padgett K, Casillas V, Punnen S, Abramowitz M, Pollack A, Stoyanova R. Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy. Strahlenther Onkol. 2017 Jan;193(1):13-21. Pubmedid: 27761612. Pmcid: PMC5559220.
  • Ahmed AA, Holliday EB, Ileto J, Yoo SK, Green M, Orman A, Deville C, Jagsi R, Haffty BG, Wilson LD. Close to Home: Employment Outcomes for Recent Radiation Oncology Graduates. Int J Radiat Oncol Biol Phys. 2016 07;95(3):1017-1021. Pubmedid: 27302515.
  • Bossart EL, Stoyanova R, Sandler K, Studenski M, Orman A, Abramowitz M, Pollack A. Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 06;95(2):827-834. Pubmedid: 27020109.
  • Orman A, Markoe A, Johnstone PA. Leptomeningeal failure of retinoblastoma. Pediatr Blood Cancer. 2015 Mar;62(3):533-535. Pubmedid: 25262657.
  • Orman A, Pollack A, Stoyanova R, Bossart E, Kwon D, Abramowitz M. (S010) A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial-Feasibility and Acute Toxicity. Oncology (Williston Park). 2015 Apr;29(4 Suppl 1). Pubmedid: 25930776.
  • Orman A, Koru-Sengul T, Miao F, Markoe A, Panoff JE. The modern role of radiation therapy in treating advanced-stage retinoblastoma: long-term outcomes and racial differences. Int J Radiat Oncol Biol Phys. 2014 Dec;90(5):1037-1043. Pubmedid: 25442037.
  • Brannan AG, Johnstone PA, Cooper J. Extracapsular tumor extension in cervical lymph nodes: reconciling the literature and seer data. Head Neck. 2011 Apr;33(4):525-528. Pubmedid: 20824808.